Clinical Trials Directory

Trials / Unknown

UnknownNCT01720420

A Clinical Evaluation of NobelProcera Implant Bar Overdenture

A Clinical Evaluation of NobelProceraTM Implant Bar Overdenture in the Mandible or Maxilla on 4 NobelReplaceTM CC Implants

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
77 (actual)
Sponsor
Nobel Biocare · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

AN OPEN 5-YEAR PROSPECTIVE, CLINICAL MULTI-CENTER STUDY on NobelProcera Implant Bar Titanium with Locator attachment and related Overdenture on 4 NobelReplace implants with conical connection (CC) in the mandible/maxilla.

Detailed description

Study centers: 8 centers in 4 countries Objectives of the study: Primary Objective: To evaluate and compare the clinical marginal bone level change (MBL) around the NobelReplaceTM CC implants supporting NobelProceraTM Implant Bar Overdenture (fixed-removable) in the mandible with the clinical marginal bone level change (MBL) of the NobelReplaceTM CC implants supporting NobelProceraTM Implant Bar Overdenture (fixed-removable) in the maxilla for a period of 5 years. Secondary Objectives: 1. To evaluate and compare the cumulative survival rate (CSR) of the NobelReplaceTM CC implants supporting NobelProceraTM Implant Bar Overdenture (fixed-removable) in the mandible with the cumulative survival rate (CSR) of the NobelReplaceTM CC implants supporting NobelProceraTM Implant Bar Overdenture (fixed-removable) in the maxilla for a period of 5 years. 2. To evaluate and compare the cumulative survival rate (CSR) of NobelProceraTM Implant Bar Overdenture (fixed-removable) on four (4) NobelReplace CC implants in the mandible with the cumulative survival rate (CSR) of NobelProceraTM Implant Bar Overdenture (fixed-removable) on four (4) NobelReplace CC implants in the maxilla after 5 years. 3. To evaluate the clinical behaviour (soft tissue behavior, clinical function, patient satisfaction, Quality of Life and prosthetic maintenance needs such as wear, chipping of denture teeth, need for exchange of attachment components) of NobelProceraTM Implant Bar Overdenture (fixed-removable) in the mandible and maxilla over 5 years of clinical function. Study design 5-year, open, prospective, clinical multi-center study. Number of subjects 76 (in total), 7-9 per center Patient population Adult female or male, at least 18 (or age of consent) and not older than 70 years, suitable for treatment with implant supported bar overdentures in the edentulous mandible or maxilla.

Conditions

Interventions

TypeNameDescription
DEVICENobelReplace CC, NobelProcera Implant BarImplants titanium with conical connection, individualized titanium bar

Timeline

Start date
2012-10-01
Primary completion
2020-04-01
Completion
2020-12-01
First posted
2012-11-02
Last updated
2018-07-16

Locations

7 sites across 2 countries: Germany, Italy

Source: ClinicalTrials.gov record NCT01720420. Inclusion in this directory is not an endorsement.